Literature DB >> 2973647

Glycolytic enzyme activities in breast cancer metastases.

A Hennipman1, B A van Oirschot, J Smits, G Rijksen, G E Staal.   

Abstract

The activities of hexokinase, phosphofructokinase, aldolase, enolase and pyruvate kinase were studied in breast cancer metastases occurring at various sites and compared with the enzyme activities in a series of primary breast cancers. The activities of all enzymes studied were significantly higher in the metastases compared to the primary tumors (p less than or equal to 0.05). However, no changes in the isoenzyme patterns of enolase and pyruvate kinase were observed when the metastases were compared with primary breast cancers. Differences in location of the metastases did not lead to differences in enzyme activities. Our data suggest an association of an increasing rate of glycolysis with tumor progression.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2973647     DOI: 10.1159/000217568

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  23 in total

1.  Evidence That Does Not Support Pyruvate Kinase M2 (PKM2)-catalyzed Reaction as a Rate-limiting Step in Cancer Cell Glycolysis.

Authors:  Jiansheng Xie; Chunyan Dai; Xun Hu
Journal:  J Biol Chem       Date:  2016-02-25       Impact factor: 5.157

2.  Progressive increase of glucose transporter-3 (GLUT-3) expression in estrogen-induced breast carcinogenesis.

Authors:  M A Kocdor; H Kocdor; J S Pereira; J E Vanegas; I H Russo; J Russo
Journal:  Clin Transl Oncol       Date:  2012-10-02       Impact factor: 3.405

3.  Role of sp transcription factors in the regulation of cancer cell metabolism.

Authors:  Michael C Archer
Journal:  Genes Cancer       Date:  2011-07

Review 4.  Targeting metabolism in breast cancer: How far we can go?

Authors:  Jing-Pei Long; Xiao-Na Li; Feng Zhang
Journal:  World J Clin Oncol       Date:  2016-02-10

5.  Metabolic alterations in mammary cancer prevention by withaferin A in a clinically relevant mouse model.

Authors:  Eun-Ryeong Hahm; Joomin Lee; Su-Hyeong Kim; Anuradha Sehrawat; Julie A Arlotti; Sruti S Shiva; Rohit Bhargava; Shivendra V Singh
Journal:  J Natl Cancer Inst       Date:  2013-07-02       Impact factor: 13.506

6.  The increment in standardized uptake value determined using dual-phase 18F-FDG PET is a promising prognostic factor in non-small-cell lung cancer.

Authors:  Helen H W Chen; Bi-Fang Lee; Wu-Chou Su; Yu-Hsuan Lai; Hung-Yu Chen; How-Ran Guo; Wei-Jen Yao; Nan-Tsing Chiu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-06-07       Impact factor: 9.236

7.  Restorative effect of Kalpaamruthaa, an indigenous preparation, on oxidative damage in mammary gland mitochondrial fraction in experimental mammary carcinoma.

Authors:  Shanmugam Arulkumaran; Vanu Ramkumar Ramprasath; Palanivelu Shanthi; Panchanatham Sachdanandam
Journal:  Mol Cell Biochem       Date:  2006-09-05       Impact factor: 3.396

8.  Variable toxicological response to the loss of OXPHOS through 1-methyl-4-phenylpyridinium-induced mitochondrial damage and anoxia in diverse neural immortal cell lines.

Authors:  Elizabeth A Mazzio; Youssef I Soliman; Karam F A Soliman
Journal:  Cell Biol Toxicol       Date:  2010-04-18       Impact factor: 6.691

Review 9.  Hypoxia, glucose metabolism and the Warburg's effect.

Authors:  Ramon Bartrons; Jaime Caro
Journal:  J Bioenerg Biomembr       Date:  2007-06       Impact factor: 2.945

Review 10.  Cancer's craving for sugar: an opportunity for clinical exploitation.

Authors:  S Yeluri; B Madhok; K R Prasad; P Quirke; D G Jayne
Journal:  J Cancer Res Clin Oncol       Date:  2009-05-05       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.